1-(4-(methylthio)phenyl)-5-phenoxy-1,4-pentadione | 189955-86-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-(4-(methylthio)phenyl)-5-phenoxy-1,4-pentadione
• 英文别名: 1-(4-(Methylthio)phenyl)-5-phenoxypenta-1,4-dione；1-(4-Methylsulfanylphenyl)-5-phenoxypentane-1,4-dione
• CAS: 189955-86-0
• 化学式: C₁₈H₁₈O₃S
• 分子量: 314.405
• InChiKey: NRZAMFPNVHKKMY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  22
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  68.7
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-(4-(methylthio)phenyl)-5-phenoxy-1,4-pentadione 在 Oxone 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 甲醇 、 水 、 丙酮 为溶剂， 反应 19.0h， 生成 3-(4-(methylsulfonyl)phenyl)-2-phenoxycyclopent-2-enone
  参考文献：
  名称：

  2,3-Diarylcyclopentenones as Orally Active, Highly Selective Cyclooxygenase-2 Inhibitors

  摘要：

  Cyclopentenones containing a 4-(methylsulfonyl)phenyl group in the 3-position and a phenyl ring in the 2-position are selective inhibitors of cyclooxygenase-2 (COX-2). The selectivity for COX-2 over COX-1 is dramatically improved by substituting the 2-phenyl group with halogens in the meta position or by replacing the phenyl ring with a 2- or 3-pyridyl ring. Thus the 3,5-difluorophenyl derivative 7 (L1776,967) and the 3-pyridyl derivative 13 (L-784,506) are particularly interesting as potential antiinflammatory agents with reduced side-effect profiles. Both exhibit good oral bioavailability and are potent in standard models of pain, fever, and inflammation yet have a much reduced effect on the GI integrity of rats compared to standard nonsteroidal antiflammatory drugs.

  DOI：

  10.1021/jm980642l
• 作为产物：
  描述：

  苯氧甲基乙烯基酮 、 4-(甲基巯基)苯甲醛 在 3-苄基羟乙基甲基噻唑氯化锂 、 三乙胺 作用下， 以 1,4-二氧六环 为溶剂， 以140 mg的产率得到1-(4-(methylthio)phenyl)-5-phenoxy-1,4-pentadione
  参考文献：
  名称：

  2,3-Diarylcyclopentenones as Orally Active, Highly Selective Cyclooxygenase-2 Inhibitors

  摘要：

  Cyclopentenones containing a 4-(methylsulfonyl)phenyl group in the 3-position and a phenyl ring in the 2-position are selective inhibitors of cyclooxygenase-2 (COX-2). The selectivity for COX-2 over COX-1 is dramatically improved by substituting the 2-phenyl group with halogens in the meta position or by replacing the phenyl ring with a 2- or 3-pyridyl ring. Thus the 3,5-difluorophenyl derivative 7 (L1776,967) and the 3-pyridyl derivative 13 (L-784,506) are particularly interesting as potential antiinflammatory agents with reduced side-effect profiles. Both exhibit good oral bioavailability and are potent in standard models of pain, fever, and inflammation yet have a much reduced effect on the GI integrity of rats compared to standard nonsteroidal antiflammatory drugs.

  DOI：

  10.1021/jm980642l

文献信息

• [EN] (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES AS COX-2 INHIBITORS<br/>[FR] (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES EN TANT QU'INHIBITEURS DU COX-2
  申请人：MERCK FROSST CANADA INC.

  公开号：WO1997014691A1

  公开（公告）日：1997-04-24

  (EN) The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).(FR) Cette invention, qui porte sur le nouveau composé répondant à la formule (I), composé s'avérant efficace dans le traitement de maladies liées à la cyclo-oxygénase-2, a également trait à certaines compositions pharmaceutiques qui, contenant des composés de ladite formule (I), servent à traiter lesdites maladies.

  该发明涉及一种新的化合物(I)的使用，该化合物可用于治疗环氧合酶-2介导的疾病。该发明还涉及一些药物组合物，用于治疗环氧合酶-2介导的疾病，其中包括化合物(I)。
• [EN] 3,4-DIARYL-2-HYDROXY-2,5-DIHYDROFURANS AS PRODRUGS TO COX-2 INHIBITORS<br/>[FR] 3,4-DIARYLE-2-HYDROXY-2,5-DIHYDROFURANS UTILISES COMME PROMEDICAMENTS POUR INHIBITEURS DE COX-2
  申请人：MERCK FROSST CANADA INC.

  公开号：WO1997016435A1

  公开（公告）日：1997-05-09

  (EN) The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).(FR) L'invention se rapporte à un nouveau composé de la formule (I) utile dans le traitement de pathologies induites par la cyclooxygénase-2. L'invention se rapporte également à certaines compositions pharmaceutiques destinées au traitement de pathologies induites par la cyclooxygénase-2 et comprenant les composés de la formule (I).

  该发明涵盖了式（I）的新型化合物，可用于治疗环氧合酶-2介导的疾病。该发明还涵盖了某些含有式（I）化合物的药物组合物，用于治疗环氧合酶-2介导的疾病。
• ALKYLATED STYRENES AS PRODRUGS TO COX-2 INHIBITORS
  申请人：Merck Frosst Canada & Co.

  公开号：EP0882016B1

  公开（公告）日：2000-05-31
• (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES AS COX-2 INHIBITORS
  申请人：MERCK FROSST CANADA INC.

  公开号：EP0863891A1

  公开（公告）日：1998-09-16
• 3,4-DIARYL-2-HYDROXY-2,5-DIHYDROFURANS AS PRODRUGS TO COX-2 INHIBITORS
  申请人：Merck Frosst Canada & Co.

  公开号：EP0904269B1

  公开（公告）日：2002-01-23